Javascript must be enabled to continue!
Lesion-Induced Blepharospasm: Epidemiology and Clinical Characteristics
View through CrossRef
Background: Lesion-induced blepharospasm is considered rare. However, this information is based on a small number of heterogenous retrospective cohorts without routine neuroimaging.
Objectives: To study the epidemiology and clinical characteristics of lesion-induced blepharospasm.
Methods: Patients with blepharospasm with uncertain etiology prior to brain imaging were systematically searched from the electronic medical records of Turku University Hospital (1996–2022). Clinical information and imaging data were extracted from the patients’ records and re-evaluated by the investigators. Etiology of blepharospasm was evaluated by an in-depth review of the clinical information in the context of available literature on lesion-induced dystonias. The prevalence and annual incidence of blepharospasm were calculated based on the annual population count in the area.
Results: The search identified 57 patients, of whom four (7.0%) were considered to have lesion-induced blepharospasm, corresponding to a population-based prevalence of 2.5 per million and annual incidence of 0.3 per million. All patients with lesion-induced blepharospasm had atypical features, which were all significantly more common than in patients with idiopathic blepharospasm (P < 0.05).
Conclusions: Lesion-induced blepharospasm is more common than thought previously. However, all these patients showed atypical features, suggesting that brain imaging in blepharospasm can be limited to patients with atypical features only.
Highlights
This study investigated the epidemiology of lesion-induced blepharospasm by systematically re-evaluating all patients with blepharospasm with uncertain etiology prior to structural brain imaging from a university hospital (1996–2022).
Our results show that lesion-induced blepharospasm is more common that thought previously (7.0% of included patients, prevalence 2.5 per million, annual incidence 0.3 per million).
All patients with lesion-induced blepharospasm showed clinical features that were considered atypical for idiopathic blepharospasm, indicating that routine brain imaging is not needed in patients with typical symptoms.
Ubiquity Press, Ltd.
Title: Lesion-Induced Blepharospasm: Epidemiology and Clinical Characteristics
Description:
Background: Lesion-induced blepharospasm is considered rare.
However, this information is based on a small number of heterogenous retrospective cohorts without routine neuroimaging.
Objectives: To study the epidemiology and clinical characteristics of lesion-induced blepharospasm.
Methods: Patients with blepharospasm with uncertain etiology prior to brain imaging were systematically searched from the electronic medical records of Turku University Hospital (1996–2022).
Clinical information and imaging data were extracted from the patients’ records and re-evaluated by the investigators.
Etiology of blepharospasm was evaluated by an in-depth review of the clinical information in the context of available literature on lesion-induced dystonias.
The prevalence and annual incidence of blepharospasm were calculated based on the annual population count in the area.
Results: The search identified 57 patients, of whom four (7.
0%) were considered to have lesion-induced blepharospasm, corresponding to a population-based prevalence of 2.
5 per million and annual incidence of 0.
3 per million.
All patients with lesion-induced blepharospasm had atypical features, which were all significantly more common than in patients with idiopathic blepharospasm (P < 0.
05).
Conclusions: Lesion-induced blepharospasm is more common than thought previously.
However, all these patients showed atypical features, suggesting that brain imaging in blepharospasm can be limited to patients with atypical features only.
Highlights
This study investigated the epidemiology of lesion-induced blepharospasm by systematically re-evaluating all patients with blepharospasm with uncertain etiology prior to structural brain imaging from a university hospital (1996–2022).
Our results show that lesion-induced blepharospasm is more common that thought previously (7.
0% of included patients, prevalence 2.
5 per million, annual incidence 0.
3 per million).
All patients with lesion-induced blepharospasm showed clinical features that were considered atypical for idiopathic blepharospasm, indicating that routine brain imaging is not needed in patients with typical symptoms.
Related Results
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
Abstract
Background
Oxymetazoline hydrochloride ophthalmic solution (0.1%) is a medication used to treat blepharoptosis. Patients who suffer from bl...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections
Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections
Purpose:
The purpose of this study was to assess blepharospasm patients regarding the effect of botulinum toxin in ocular surface parameters.
...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
BOTULINUM TOXIN TYPE A: MULTIFACETED THERAPY FOR NEUROLOGICAL, AUTONOMIC AND OCULAR DISORDERS
BOTULINUM TOXIN TYPE A: MULTIFACETED THERAPY FOR NEUROLOGICAL, AUTONOMIC AND OCULAR DISORDERS
Introduction: Botulinum toxin, a neurotoxin produced by Clostridium botulinum, is an effective form of therapy for treating conditions associated with excessive muscle activity or ...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Efficacy of EMLA Cream in Pain Reduction during Botulinum Toxin Injections for Facial Dystonias
Efficacy of EMLA Cream in Pain Reduction during Botulinum Toxin Injections for Facial Dystonias
Purpose: To determine the efficacy of EMLA cream (Eutectic Mixture of Local Anesthetics) in pain reduction while injecting botulinum toxin in patients with hemifacial spasm and ble...

